Skip to content

OneTouch Verio Reflect 024-369Recalls & reported problems

LifeScan Europe GmbH · OneTouch Verio Reflect Blood Glucose Monitoring System. System Kit. · Class 2

All models of OneTouch Verio Reflect (5)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
2
Deaths reported
0
Injuries reported
2
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00353885012959), received between Jun 20, 2025 and Jun 20, 2025 — classified as 2 injuries.

The most frequently reported specific device problem is “Device Displays Incorrect Message” (2 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 2 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520262
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Device Displays Incorrect Message2

Patient problems

  • Elevated Ketones/ Diabetic Ketoacidosis2
  • Hyperglycemia2
  • Syncope/Fainting2

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • InjuryJun 20, 2025Device Displays Incorrect Message; Device Displays Incorrect Message

    ON (B)(6) 2025, THE LAY USER/PATIENT CONTACTED LIFESCAN (LFS) UNITED STATES, THE LAY USER/PATIENT CONTACTED LIFESCAN (LFS) USA, ALLEGING THAT THEIR ONETOUCH VERIO REFLECT METER WAS DISPLAYING ERROR 2, 4 AND 6 MESSAGES. THIS COMPLAINT WAS CLASSIFIED BASED ON INFORMATION OBTAINED BY THE CUSTOMER CARE AGENT (CCA) DURING THE INITIAL CALL. THE PATIENT REPORTED THAT THE ALLEGED ISSUE BEGAN AT AN UNSPECIFIED DATE/TIME APPROXIMATELY ONE AND A HALF WEEKS BEFORE THE END OF (B)(6) 2025. THE PATIENT MANAGES THEIR DIABETES WITH SELF-ADJUSTED INSULIN (LANTUS AND HUMALOG, DOSES NOT SPECIFIED, TAKEN DAILY) AND THE ADVISED THAT IN RESPONSE TO THE ALLEGED ISSUE, THEY STOPPED ADMINISTERING THEIR MEDICATION. THE PATIENT ALLEGED THAT AN UNSPECIFIED TIME AFTER THE ALLEGED ISSUE(S) BEGAN, THEY ¿FELT HIGH GLUCOSE¿, THAT THEY ¿PASSED OUT AND HAD DIABETIC KETOACIDOSIS¿. THE PATIENT ADVISED THAT THEY CONTACTED EMERGENCY MEDICAL SERVICES (EMS) WHO REPORTEDLY ATTENDED AND SUBSEQUENTLY ADMINISTERED ¿INSULIN DRIP, SODIUM, WATER AND POTASSIUM¿. THE CUSTOMER WAS UNABLE AND/OR UNWILLING TO CONFIRM IF THEIR BLOOD GLUCOSE WAS MEASURED AT THE TIME OF EMS ARRIVAL. AT THE TIME OF TROUBLESHOOTING, THE CCA ESTABLISHED THA

    Patient problems: Elevated Ketones/ Diabetic Ketoacidosis; Hyperglycemia; Syncope/Fainting

    MAUDE report 22296367 ↗
  • InjuryJun 20, 2025Device Displays Incorrect Message; Device Displays Incorrect Message

    ON (B)(6) 2025, THE LAY USER/PATIENT CONTACTED LIFESCAN (LFS) UNITED STATES, THE LAY USER/PATIENT CONTACTED LIFESCAN (LFS) USA, ALLEGING THAT THEIR ONETOUCH VERIO REFLECT METER WAS DISPLAYING ERROR 2, 4 AND 6 MESSAGES. THIS COMPLAINT WAS CLASSIFIED BASED ON INFORMATION OBTAINED BY THE CUSTOMER CARE AGENT (CCA) DURING THE INITIAL CALL. THE PATIENT REPORTED THAT THE ALLEGED ISSUE BEGAN AT AN UNSPECIFIED DATE/TIME APPROXIMATELY ONE AND A HALF WEEKS BEFORE THE END OF (B)(6) 2025. THE PATIENT MANAGES THEIR DIABETES WITH SELF-ADJUSTED INSULIN (LANTUS AND HUMALOG, DOSES NOT SPECIFIED, TAKEN DAILY) AND THE ADVISED THAT IN RESPONSE TO THE ALLEGED ISSUE, THEY STOPPED ADMINISTERING THEIR MEDICATION. THE PATIENT ALLEGED THAT AN UNSPECIFIED TIME AFTER THE ALLEGED ISSUE(S) BEGAN, THEY ¿FELT HIGH GLUCOSE¿, THAT THEY ¿PASSED OUT AND HAD DIABETIC KETOACIDOSIS¿. THE PATIENT ADVISED THAT THEY CONTACTED EMERGENCY MEDICAL SERVICES (EMS) WHO REPORTEDLY ATTENDED AND SUBSEQUENTLY ADMINISTERED ¿INSULIN DRIP, SODIUM, WATER AND POTASSIUM¿. THE CUSTOMER WAS UNABLE AND/OR UNWILLING TO CONFIRM IF THEIR BLOOD GLUCOSE WAS MEASURED AT THE TIME OF EMS ARRIVAL. AT THE TIME OF TROUBLESHOOTING, THE CCA ESTABLISHED THA

    Patient problems: Elevated Ketones/ Diabetic Ketoacidosis; Hyperglycemia; Syncope/Fainting

    MAUDE report 22296269 ↗

Other System, Test, Blood Glucose, Over The Counter devices

All System, Test, Blood Glucose, Over The Counter devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page